Company
ParinGenix Inc.
- Business model
- B2B
Record updated 28 September 2026
About
ParinGenix Inc. was founded to develop 2-O, 3-O desulfated heparin, a nonanticoagulant heparin derivative, for the treatment of inflammatory diseases. The company has advanced the drug through Phase II clinical trials for the treatment of COPD.